Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Tretinoin Cream USP, 0.1%, (USRLD: Retin-A Cream, 0.1%).

Tretinoin cream is used to treat acne. The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India).

Tretinoin Cream USP, 0.1% had annual sales of USD 54.8 mn in the United States (IQVIA MAT Feb-24).

The group now has 394 approvals and has so far filed over 460* ANDAs since the commencement of the filing process in FY 2003-04.